Claire Garwood
Overview
Explore the profile of Claire Garwood including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bryant L, Free R, Woolf K, Melbourne C, Guyatt A, John C, et al.
Int J Epidemiol
. 2022 Aug;
52(1):e38-e45.
PMID: 36029521
No abstract available.
2.
Woolf K, Melbourne C, Bryant L, Guyatt A, McManus I, Gupta A, et al.
BMJ Open
. 2021 Sep;
11(9):e050647.
PMID: 34535484
Introduction: The COVID-19 pandemic has resulted in significant morbidity and mortality and devastated economies globally. Among groups at increased risk are healthcare workers (HCWs) and ethnic minority groups. Emerging evidence...
3.
Grayson J, Baumgartner M, Souza C, Dawes S, Ghafir El Idrissi I, Louth J, et al.
Chem Sci
. 2021 Jun;
12(10):3768-3785.
PMID: 34163650
Amyloid β oligomers (Aβo) are the main toxic species in Alzheimer's disease, which have been targeted for single drug treatment with very little success. In this work we report a...
4.
de Matos A, Blazquez-Sanchez M, Bento-Oliveira A, de Almeida R, Nunes R, Lopes P, et al.
J Med Chem
. 2020 Sep;
63(20):11663-11690.
PMID: 32959649
Despite the rapidly increasing number of patients suffering from type 2 diabetes, Alzheimer's disease, and diabetes-induced dementia, there are no disease-modifying therapies that are able to prevent or block disease...
5.
Simpson J, Ince P, Matthews F, Shaw P, Heath P, Brayne C, et al.
Neuropathol Appl Neurobiol
. 2014 Dec;
41(4):483-96.
PMID: 25443110
Aims: Population-based studies have shown that approximately 20% of the ageing population (aged 65 years and over) with dementia have little or no classical Alzheimer-type neuropathology. Cumulative DNA damage and...
6.
Viggars A, Wharton S, Simpson J, Matthews F, Brayne C, Savva G, et al.
Neurosci Lett
. 2011 Oct;
505(1):25-30.
PMID: 21970975
Impairment of the blood brain barrier (BBB) in human brain ageing and its relationship to Alzheimer-type pathology remains poorly defined. We have investigated the BBB in temporal cortex of brain...
7.
Noble W, Garwood C, Stephenson J, Kinsey A, Hanger D, Anderton B
FASEB J
. 2008 Nov;
23(3):739-50.
PMID: 19001528
Alzheimer's disease (AD) is characterized by the presence of neurofibrillary tangles of hyperphosphorylated, aggregated tau protein and extracellular deposits of beta-amyloid peptide. Increased beta-amyloid levels are thought to precede tangle...
8.
Kelleher I, Garwood C, Hanger D, Anderton B, Noble W
J Neurochem
. 2007 Oct;
103(6):2256-67.
PMID: 17908241
Hyperphosphorylated tau aggregates are the core constituent of neurofibrillary tangles. Recent research has shown a division between the presence of tangles, neurodegeneration and subsequent memory impairment, raising the possibility that...